E
MediXall Group, Inc.
MDXL
$0.0035
$0.00026.06%
E
Sell
3/14/2023Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 2/23/2023 due to an increase in the valuation index.
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 2/23/2023 due to an increase in the valuation index.
E
Sell
2/8/2023Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 2/8/2023 due to a major decline in the solvency index and valuation index. The quick ratio declined from 0.13 to 0.02, and debt to equity increased from -0.78 to -0.7.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 2/8/2023 due to a major decline in the solvency index and valuation index. The quick ratio declined from 0.13 to 0.02, and debt to equity increased from -0.78 to -0.7.
D
Sell
8/2/2022Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 8/2/2022 due to a large increase in the solvency index, growth index and valuation index. Debt to equity declined from -0.2 to -0.72, total revenue increased 104.98% from -$158.7 to $7.9, and the quick ratio increased from 0.05 to 0.08.
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 8/2/2022 due to a large increase in the solvency index, growth index and valuation index. Debt to equity declined from -0.2 to -0.72, total revenue increased 104.98% from -$158.7 to $7.9, and the quick ratio increased from 0.05 to 0.08.
E
Sell
7/18/2022Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 7/18/2022 due to a large decline in the total return index and volatility index.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 7/18/2022 due to a large decline in the total return index and volatility index.
D
Sell
6/30/2022Downgrade
MediXall Group, Inc. (MDXL) was downgraded to D- from D on 6/30/2022 due to a decline in the total return index and volatility index.
MediXall Group, Inc. (MDXL) was downgraded to D- from D on 6/30/2022 due to a decline in the total return index and volatility index.
D
Sell
5/16/2022Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and valuation index.
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and valuation index.
E
Sell
5/13/2022Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 05/04/2022.
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/3/2022Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 5/3/2022 due to a large decline in the solvency index and total return index.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 5/3/2022 due to a large decline in the solvency index and total return index.
D
Sell
4/21/2022Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 4/21/2022 due to an increase in the valuation index.
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 4/21/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.02 to 3.64.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.02 to 3.64.
D
Sell
11/9/2021Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index and total return index.
MediXall Group, Inc. (MDXL) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index and total return index.
E
Sell
11/8/2021Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 11/08/2021.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D on 11/08/2021.
D
Sell
11/4/2021Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D from D- on 11/4/2021 due to a large increase in the total return index, growth index and volatility index. Total revenue increased 4,948.48% from $3.3 to $166.6.
MediXall Group, Inc. (MDXL) was upgraded to D from D- on 11/4/2021 due to a large increase in the total return index, growth index and volatility index. Total revenue increased 4,948.48% from $3.3 to $166.6.
D
Sell
9/17/2021Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 9/17/2021 due to an increase in the total return index and volatility index.
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 9/17/2021 due to an increase in the total return index and volatility index.
E
Sell
8/20/2021Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 8/20/2021 due to a decline in the valuation index and total return index.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 8/20/2021 due to a decline in the valuation index and total return index.
D
Sell
8/5/2021Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 8/5/2021 due to an increase in the growth index and valuation index. Earnings per share increased from -$0.0208 to -$0.0138, and EBIT increased 32.31% from -$1.97M to -$1.33M.
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 8/5/2021 due to an increase in the growth index and valuation index. Earnings per share increased from -$0.0208 to -$0.0138, and EBIT increased 32.31% from -$1.97M to -$1.33M.
E
Sell
6/7/2021Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 6/7/2021 due to a decline in the volatility index and total return index.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 6/7/2021 due to a decline in the volatility index and total return index.
D
Sell
1/21/2021Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 1/21/2021 due to an increase in the volatility index and total return index.
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 1/21/2021 due to an increase in the volatility index and total return index.
E
Sell
11/18/2020Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 11/18/2020 due to a decline in the growth index and volatility index. Operating cash flow declined 43.75% from -$826.7 to -$1.19M.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 11/18/2020 due to a decline in the growth index and volatility index. Operating cash flow declined 43.75% from -$826.7 to -$1.19M.
D
Sell
11/9/2020Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 11/9/2020 due to an increase in the total return index, volatility index and valuation index.
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 11/9/2020 due to an increase in the total return index, volatility index and valuation index.
E
Sell
6/8/2020Downgrade
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 6/8/2020 due to a decline in the total return index, volatility index and valuation index.
MediXall Group, Inc. (MDXL) was downgraded to E+ from D- on 6/8/2020 due to a decline in the total return index, volatility index and valuation index.
D
Sell
5/15/2020Downgrade
MediXall Group, Inc. (MDXL) was downgraded to D- from D on 5/15/2020 due to a major decline in the total return index, efficiency index and volatility index. Net income declined 80.63% from -$714.9 to -$1.29M.
MediXall Group, Inc. (MDXL) was downgraded to D- from D on 5/15/2020 due to a major decline in the total return index, efficiency index and volatility index. Net income declined 80.63% from -$714.9 to -$1.29M.
D
Sell
3/29/2019Downgrade
MediXall Group, Inc. (MDXL) was downgraded to D from D+ on 3/29/2019 due to a decline in the volatility index.
MediXall Group, Inc. (MDXL) was downgraded to D from D+ on 3/29/2019 due to a decline in the volatility index.
D
Sell
2/11/2019Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D+ from D on 2/11/2019 due to a large increase in the efficiency index, valuation index and volatility index.
MediXall Group, Inc. (MDXL) was upgraded to D+ from D on 2/11/2019 due to a large increase in the efficiency index, valuation index and volatility index.
D
Sell
8/16/2018Downgrade
MediXall Group, Inc. (MDXL) was downgraded to D from D+ on 8/16/2018 due to a significant decline in the efficiency index, total return index and valuation index.
MediXall Group, Inc. (MDXL) was downgraded to D from D+ on 8/16/2018 due to a significant decline in the efficiency index, total return index and valuation index.
D
Sell
7/2/2018Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D+ from D on 7/2/2018 due to a significant increase in the efficiency index, total return index and solvency index. Total capital increased 65.79% from -$224.5 to -$76.8, and the quick ratio increased from 0.32 to 0.39.
MediXall Group, Inc. (MDXL) was upgraded to D+ from D on 7/2/2018 due to a significant increase in the efficiency index, total return index and solvency index. Total capital increased 65.79% from -$224.5 to -$76.8, and the quick ratio increased from 0.32 to 0.39.
D
Sell
1/2/2018Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D from D- on 1/2/2018 due to a large increase in the solvency index and growth index. The quick ratio increased from 0.32 to 0.37, earnings per share increased from -$0.0071 to -$0.0062, and EBIT increased 8.59% from -$376.1 to -$343.8.
MediXall Group, Inc. (MDXL) was upgraded to D from D- on 1/2/2018 due to a large increase in the solvency index and growth index. The quick ratio increased from 0.32 to 0.37, earnings per share increased from -$0.0071 to -$0.0062, and EBIT increased 8.59% from -$376.1 to -$343.8.
D
Sell
9/1/2017Upgraded
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 9/1/2017 due to an increase in the total return index and growth index.
MediXall Group, Inc. (MDXL) was upgraded to D- from E+ on 9/1/2017 due to an increase in the total return index and growth index.
E
Sell
8/22/2017None
MediXall Group, Inc. (MDXL) was downgraded to E+ from U on 08/22/2017.
MediXall Group, Inc. (MDXL) was downgraded to E+ from U on 08/22/2017.
OTC PK
01/28/2025 10:57AM Eastern
Quotes delayed
